New York 9/20/2013 1:16:50 AM
News / Finance

Researchers in Switzerland Use Arrayit Corporation’s Microarray Technology

Listonstreetpulse.com announces that researchers at the Institute of Bioengineering, School of Engineering and School of Life Science, Ecole Polytechnique Federale de Lausanne, Switzerland have used Arrayit Corporation’s (OTC: ARYC) Arrayit Microarray Technology to develop a live cell-based drug discovery method to reduce and replace drug trials in animals and live persons. 

Traditionally, researchers have relied on laborious testing in laboratory animals and human patients for drug discovery. However, this practice is expensive and there are also ethical concerns, as well as possible health risks. The groundbreaking scientific discovery, which was made by Dr. Kristina Woodruff, Dr. Luis M. Fidalgo, Dr. Samy Gobaa, Dr. Matthias P. Lutolf and Dr. Sebastian J. Maerkl,  has been published in the 2013 edition of Nature Methods and entitled, “Live mammalian cell arrays”, and can be read online at http://www.nature.com/nmeth/journal/v10/n6/pdf/nmeth.2473.pdf. 

The Swiss researchers used Arrayit’s patented and proprietary microarray printing technology and consumables to manufacture nanowell microarrays to screen drug compounds in a miniaturized and massively parallel manner. This is similar to the manner in which computer chips process binary information. 

The worldwide market for cell-based assays is forecast to reach $4.7 billion by 2016, a market segment that ARYC expects to drive revenue and earnings as the pharmaceutical industry increasingly uses its technology to streamline the commercialization of new blockbuster medicines. 

To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/

About Arrayit Corporation                            
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.

About Liston Street Pulse                                                 
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.

###